advertisement

Topcon

Pellegrini M 12

Showing records 1 to 12 | Display all abstracts from Pellegrini M

91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Passani A
Journal of clinical medicine 2020; 9:
91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Giannaccare G
European Journal of Ophthalmology 2020; 0: 1120672120969612
91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Posarelli C
Journal of clinical medicine 2020; 9:
91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Pellegrini M
European Journal of Ophthalmology 2020; 0: 1120672120969612
91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Sframeli AT
Journal of clinical medicine 2020; 9:
91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Bernabei F
European Journal of Ophthalmology 2020; 0: 1120672120969612
91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Perciballi L
Journal of clinical medicine 2020; 9:
91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Senni C; Aloi M
European Journal of Ophthalmology 2020; 0: 1120672120969612
91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Pellegrini M
Journal of clinical medicine 2020; 9:
91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Scalzo GC
European Journal of Ophthalmology 2020; 0: 1120672120969612
91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Guidi G; Figus M
Journal of clinical medicine 2020; 9:
91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Ceravolo D; Iovino C; Scorcia V
European Journal of Ophthalmology 2020; 0: 1120672120969612

Issue 21-4

Change Issue


advertisement

Oculus